FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386922082> ?p ?o ?g. }

• W4386922082 endingPage "5225" @default.
• W4386922082 startingPage "5214" @default.
• W4386922082 abstract "Chemotherapeutic agents targeting energy metabolism have not achieved satisfactory results in different types of tumors. Herein, we developed an RNA interference (RNAi) method against adenosine triphosphate (ATP) by constructing an interfering plasmid-expressing ATP-binding RNA aptamer, which notably inhibited the growth of prostate cancer cells through diminishing the availability of cytoplasmic ATP and impairing the homeostasis of energy metabolism, and both glycolysis and oxidative phosphorylation were suppressed after RNAi treatment. Further identifying the mechanism underlying the effects of ATP aptamer, we surprisingly found that it markedly reduced the activity of membrane ionic channels and membrane potential which led to the dysfunction of mitochondria, such as the decrease of mitochondrial number, reduction in the respiration rate, and decline of mitochondrial membrane potential and ATP production. Meanwhile, the shortage of ATP impeded the formation of lamellipodia that are essential for the movement of cells, consequently resulting in a significant reduction of cell migration. Both the downregulation of the phosphorylation of AMP-activated protein kinase (AMPK) and endoplasmic reticulum kinase (ERK) and diminishing of lamellipodium formation led to cell apoptosis as well as the inhibition of angiogenesis and invasion. In conclusion, as the first RNAi modality targeting the blocking of ATP consumption, the present method can disturb the respiratory chain and ATP pool, which provides a novel regime for tumor therapies.." @default.
• W4386922082 created "2023-09-22" @default.
• W4386922082 creator A5005166877 @default.
• W4386922082 creator A5005358531 @default.
• W4386922082 creator A5006983538 @default.
• W4386922082 creator A5009886222 @default.
• W4386922082 creator A5016313702 @default.
• W4386922082 creator A5030138838 @default.
• W4386922082 creator A5044111714 @default.
• W4386922082 creator A5048785552 @default.
• W4386922082 creator A5050626113 @default.
• W4386922082 creator A5051163930 @default.
• W4386922082 creator A5051334432 @default.
• W4386922082 creator A5053794629 @default.
• W4386922082 creator A5054795710 @default.
• W4386922082 creator A5071857215 @default.
• W4386922082 creator A5089489848 @default.
• W4386922082 date "2023-09-21" @default.
• W4386922082 modified "2023-10-18" @default.
• W4386922082 title "RNA Interference against ATP as a Gene Therapy Approach for Prostate Cancer" @default.
• W4386922082 cites W1603862075 @default.
• W4386922082 cites W1948872103 @default.
• W4386922082 cites W1980585134 @default.
• W4386922082 cites W2006873065 @default.
• W4386922082 cites W2039624553 @default.
• W4386922082 cites W2041919391 @default.
• W4386922082 cites W2046770259 @default.
• W4386922082 cites W2059738518 @default.
• W4386922082 cites W2070663123 @default.
• W4386922082 cites W2070923004 @default.
• W4386922082 cites W2076189832 @default.
• W4386922082 cites W2083002511 @default.
• W4386922082 cites W2132889264 @default.
• W4386922082 cites W2165573061 @default.
• W4386922082 cites W2329421556 @default.
• W4386922082 cites W2758067903 @default.
• W4386922082 cites W2768286346 @default.
• W4386922082 cites W2804693939 @default.
• W4386922082 cites W2883867232 @default.
• W4386922082 cites W2911081366 @default.
• W4386922082 cites W2919303028 @default.
• W4386922082 cites W2926461237 @default.
• W4386922082 cites W2969267340 @default.
• W4386922082 cites W2991618842 @default.
• W4386922082 cites W2992324722 @default.
• W4386922082 cites W3005870288 @default.
• W4386922082 cites W3021050601 @default.
• W4386922082 cites W3039811471 @default.
• W4386922082 cites W3043495494 @default.
• W4386922082 cites W3117332330 @default.
• W4386922082 cites W3119689955 @default.
• W4386922082 cites W3133158994 @default.
• W4386922082 cites W3151350205 @default.
• W4386922082 cites W3217521860 @default.
• W4386922082 cites W4210649661 @default.
• W4386922082 cites W4225279755 @default.
• W4386922082 cites W4225280580 @default.
• W4386922082 cites W4252911401 @default.
• W4386922082 cites W4283729951 @default.
• W4386922082 cites W4287881872 @default.
• W4386922082 doi "https://doi.org/10.1021/acs.molpharmaceut.3c00587" @default.
• W4386922082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37733628" @default.
• W4386922082 hasPublicationYear "2023" @default.
• W4386922082 type Work @default.
• W4386922082 citedByCount "0" @default.
• W4386922082 crossrefType "journal-article" @default.
• W4386922082 hasAuthorship W4386922082A5005166877 @default.
• W4386922082 hasAuthorship W4386922082A5005358531 @default.
• W4386922082 hasAuthorship W4386922082A5006983538 @default.
• W4386922082 hasAuthorship W4386922082A5009886222 @default.
• W4386922082 hasAuthorship W4386922082A5016313702 @default.
• W4386922082 hasAuthorship W4386922082A5030138838 @default.
• W4386922082 hasAuthorship W4386922082A5044111714 @default.
• W4386922082 hasAuthorship W4386922082A5048785552 @default.
• W4386922082 hasAuthorship W4386922082A5050626113 @default.
• W4386922082 hasAuthorship W4386922082A5051163930 @default.
• W4386922082 hasAuthorship W4386922082A5051334432 @default.
• W4386922082 hasAuthorship W4386922082A5053794629 @default.
• W4386922082 hasAuthorship W4386922082A5054795710 @default.
• W4386922082 hasAuthorship W4386922082A5071857215 @default.
• W4386922082 hasAuthorship W4386922082A5089489848 @default.
• W4386922082 hasConcept C104317684 @default.
• W4386922082 hasConcept C121608353 @default.
• W4386922082 hasConcept C166703698 @default.
• W4386922082 hasConcept C185592680 @default.
• W4386922082 hasConcept C22615655 @default.
• W4386922082 hasConcept C2779564974 @default.
• W4386922082 hasConcept C28859421 @default.
• W4386922082 hasConcept C54009773 @default.
• W4386922082 hasConcept C54355233 @default.
• W4386922082 hasConcept C55493867 @default.
• W4386922082 hasConcept C57600042 @default.
• W4386922082 hasConcept C67705224 @default.
• W4386922082 hasConcept C86803240 @default.
• W4386922082 hasConcept C95444343 @default.
• W4386922082 hasConcept C96232424 @default.
• W4386922082 hasConceptScore W4386922082C104317684 @default.
• W4386922082 hasConceptScore W4386922082C121608353 @default.

• next